ARTS-021 shows promising antitumor activity in CCNE1-amplified cancer models April 27, 2022 No Comments
CJRS-10671 and CJRS-10672, biotherapeutic candidates with promising antitumor efficacy in vivo April 25, 2022 No Comments
EGFR-TKI TAS-3351 overcomes T790M and C797S mutations tied to NSCLC treatment resistance April 25, 2022 No Comments
AUR-103 in combination with azacytidine and bortezomib for myeloma and leukemia treatment April 20, 2022 No Comments
Plexium compound shows the promise of BRD4 degradation for prostate cancer April 20, 2022 No Comments
FGFR2-selective inhibitor CGT-0292 shows promise for treating hyperphosphatemia April 13, 2022 No Comments
Peptidomimetic TMPRSS2 inhibitor shows prophylactic and therapeutic activity against SARS-CoV-2 VOCs April 7, 2022 No Comments
RSS